Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control
DermConnect® is an official licensee of the American Academy of Dermatology.
In HealthDay News
by Healthday
Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control